Life Sciences and Voluntary Scheme for Branded Medicines Pricing and Access
(asked on 7th December 2022) - View Source
Question to the Department for Business, Energy and Industrial Strategy:
To ask the Secretary of State for Business, Energy and Industrial Strategy, what recent discussions he has had with the Secretary of State for Health and Social Care on improving the UK's standing as a global life sciences hub and the use of the Voluntary Scheme for Branded Medicines Pricing Access.
As the accountable Secretaries of State for the Life Sciences Vision, the Government and life sciences sector’s blueprint for ensuring the UK becomes a world leading science superpower and global life sciences leader, my Rt. Hon. Friends the Secretary of State for Business, Energy and Industrial Strategy and the Secretary of State for Health and Social Care are regularly engaged in discussions on how we can deliver on the ambitions of the Vision for the economy and for NHS patients.
This was the subject of discussion at the most recent Life Sciences Council on the 28th of November, where the Voluntary Scheme for Branded Medicines Pricing Access was also discussed.